Bean1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant NGS Genetic DNA Test
The Bean1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant NGS Genetic DNA Test is crucial for understanding genetic predispositions to neurological disorders. This advanced test uses Next-Generation Sequencing (NGS) technology to analyze genetic material, providing insights into potential risks associated with Spinocerebellar Ataxia Type 31.
What the Test Measures
This test specifically detects mutations in the BEAN1 gene, which are linked to Spinocerebellar Ataxia Type 31, a hereditary neurological disorder characterized by progressive loss of coordination and balance.
Who Should Consider This Test
- Individuals with a family history of Spinocerebellar Ataxia or other neurological disorders.
- Patients experiencing symptoms such as unsteady gait, difficulty with fine motor skills, or other coordination issues.
- Those who have undergone genetic counseling and wish to understand their genetic risks better.
Benefits of Taking the Test
- Identifies genetic predispositions, allowing for early intervention and management.
- Informs family planning decisions for individuals with a family history of the disorder.
- Empowers patients with knowledge about their health, enabling informed healthcare decisions.
Understanding Your Results
Results from the Bean1 Gene Spinocerebellar Ataxia Type 31 test will indicate whether or not mutations in the BEAN1 gene are present. A positive result may suggest a higher risk of developing the disorder, while a negative result can provide reassurance. It is essential to discuss your results with a healthcare provider or genetic counselor for proper interpretation and guidance.
Test Name and Price
| Discount Price | Regular Price |
|---|---|
| 400,000 NGN | 560,000 NGN |
Book the Test
To schedule your Bean1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant NGS Genetic DNA Test, please contact us at +2348110567037. Our team is ready to assist you with the booking process and any questions you may have.
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or one drop of blood on an FTA card. Before the test, a clinical history and a genetic counseling session are recommended to draw a pedigree chart of family members affected by the condition.
